The sport participation limiting injuries, musculoskeletal complaints and the SF-36v2 health survey data in Paralympic volleyball players. A long time survey.

被引:0
|
作者
Mustafins, P. [1 ]
Vetra, A. [1 ]
Schibrja, I. [2 ]
机构
[1] Riga Stradinsh Univ, Riga, Latvia
[2] Sport Med & Rehabil Ctr, Riga, Latvia
来源
PROCEEDINGS OF THE 10TH CONGRESS OF EUROPEAN FEDERATION FOR RESEARCH IN REHABILITATION - EFRR | 2009年
关键词
D O I
暂无
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
There are still very scarce data available on the sport related or sport participation limiting secondary pathology in the Paralympic contingent. We have followed through questionnaires the international Paralympic volleyball players during the years 1995 - 2008. The injury questionnaire (original questionnaire) results were obtained on the 474 international sitting volleyball players (88 female, 386 male) and 55 standing volleyball players (male). The SF-36v2 data were obtained on the 75 players (43 female, 32 male). An overall incidence of sports related participation limiting injury was 1.04 +/- 0.11 per player/season either 5.08 +/- 0.43 per 1000 training/competition hours. SF-36v2 Physical and Mental components scores (PCS and MCS) were, accordingly, 45,30 +/- 7,96 and 41,02 +/- 9,57. The injury rate in Paralympic volleyball is comparable to that in the Olympic one. PCS and MCS are below the US general population norms with MCS being statistically significantly lower. The prophylactical measures were recommended.
引用
收藏
页码:63 / +
页数:2
相关论文
共 25 条
  • [1] The Sport Participation Limiting Injuries, Musculoskeletal Complaints and the SF-36v2 Health Survey Data in Paralympic Volleyball Players
    Mustafins, Pavels
    Vetra, Aivars
    Scibrja, Irina
    INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH, 2009, 32 : S114 - S114
  • [2] DERIVATION OF INTERPRETATION THRESHOLDS FOR THE SF-36V2® HEALTH SURVEY (SF-36V2) IN RHEUMATOID ARTHRITIS
    Chen, W. H.
    Rendas-Baum, R.
    Lin, X.
    Kosinski, M.
    Bjorner, J. B.
    Bracher, M.
    VALUE IN HEALTH, 2022, 25 (01) : S247 - S247
  • [3] Normative Data, Discriminative Properties and Equivalence of SF-36v2 Health Survey in Malaysian Population
    Shafie, Asrul Akmal
    Atif, Muhammad
    Sulaiman, Syed Azhar Syed
    Asif, Muhammad
    Zahari, Che Dan
    LATIN AMERICAN JOURNAL OF PHARMACY, 2012, 31 (08): : 1117 - 1125
  • [4] PSYCHOMETRIC VALIDATION OF THE SF-36V2® HEALTH SURVEY IN AN AL AMYLOIDOSIS POPULATION
    White, M. K.
    Bayliss, M.
    McCausland, K. L.
    Guthrie, S.
    HAEMATOLOGICA, 2016, 101 : 596 - 596
  • [5] Content validation of the SF-36v2® Health Survey Acute for use in hypoparathyroidism
    Meryl Brod
    Laura Tesler Waldman
    Aimee D. Shu
    Alden Smith
    Quality of Life Research, 2023, 32 : 1795 - 1806
  • [6] Content validation of the SF-36v2® health survey with al amyloidosis patients
    White M.K.
    Bayliss M.S.
    Guthrie S.D.
    Raymond K.P.
    Rizio A.A.
    McCausland K.L.
    Journal of Patient-Reported Outcomes, 1 (1)
  • [7] Single-item electronic administration of the SF-36v2 Health Survey
    Turner-Bowker, Diane M.
    Saris-Baglama, Renee N.
    DeRosa, Michael A.
    QUALITY OF LIFE RESEARCH, 2013, 22 (03) : 485 - 490
  • [8] Single-item electronic administration of the SF-36v2 Health Survey
    Diane M. Turner-Bowker
    Renee N. Saris-Baglama
    Michael A. DeRosa
    Quality of Life Research, 2013, 22 : 485 - 490
  • [9] Disease burden of ATTR amyloidosis based on the SF-36v2® health survey
    Sanchorawala, Vaishali
    Greatsinger, Alexandra
    Staron, Andrew
    Berk, John
    Mendelson, Lisa
    Joshi, Tracy
    Burke, Natasha
    Tabatabaeepour, Nadia
    Smith, Jess
    Signorovitch, James
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2024, 31 : S86 - S86
  • [10] Content validation of the SF-36v2® Health Survey Acute for use in hypoparathyroidism
    Brod, Meryl
    Waldman, Laura Tesler
    Shu, Aimee D.
    Smith, Alden
    QUALITY OF LIFE RESEARCH, 2023, 32 (06) : 1795 - 1806